The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
Open accessPublished version of a preprint
Abstract
SARS-CoV-2 evolution threatens vaccine- and natural infection–derived immunity and the efficacy of therapeutic antibodies. To improve public health preparedness, we sought to predict which existing amino acid mutations in SARS-CoV-2 might contribute to future variants of concern. We tested the predictive value of features comprising epidemiology, evolution, immunology, and neural network–based protein sequence modeling and identified primary biological drivers of SARS-CoV-2 intrapandemic evolution. We found evidence that ACE2-mediated transmissibility and resistance to population-level host immunity has waxed and waned as a primary driver of SARS-CoV-2 evolution over time. We retroactively identified with high accuracy (area under the receiver operator characteristic curve = 0.92 to 0.97) mutations that will spread, at up to 4 months in advance, across different phases of the pandemic. The behavior of the model was consistent with a plausible causal structure where epidemiological covariates combine the effects of diverse and shifting drivers of viral fitness. We applied our model to forecast mutations that will spread in the future and characterize how these mutations affect the binding of therapeutic antibodies. These findings demonstrate that it is possible to forecast the driver mutations that could appear in emerging SARS-CoV-2 variants of concern. We validated this result against Omicron, showing elevated predictive scores for its component mutations before emergence and rapid score increase across daily forecasts during emergence. This modeling approach may be applied to any rapidly evolving pathogens with sufficiently dense genomic surveillance data, such as influenza, and unknown future pandemic viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Harris, C. R., Millman, K. J., van der Walt, S. J., Gommers, R., Virtanen, P., Cournapeau, D., Wieser, E., Taylor, J., Berg, S., Smith, N. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2649-2 · Cited by 23,826
Data, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Detecting Individual Sites Subject to Episodic Diversifying Selection
Murrell, B., Wertheim, J. O., Moola, S., Weighill, T., Scheffler, K., & Kosakovsky Pond, S. L. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002764 · Cited by 1,811
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. D. S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., et al. (2021) · Science · doi:10.1126/science.abh2644 · Cited by 1,461
Self-citationEscape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178
Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H. D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.007 · Cited by 1,016
Research works printed but not linked: 20
- A. Adiga L. Wang B. Hurt A. Peddireddy P. Porebski S. Venkatramanan B. Lewis M. Marathe All models are useful: Bayesian ensembling for robust high resolution COVID-19 forecasting. Medrxiv 2021.03.12.21253495 (2021); https://doi.org/10.1101/2021.03.12.21253495. · DOI
- H. Zhao, N. N. Merchant, A. McNulty, T. A. Radcliff, M. J. Cote, R. S. B. Fischer, H. Sang, M. G. Ory, COVID-19: Short term prediction model using daily incidence data. PLOS ONE 16, e0250110 (2021). · DOI
- E. L. Ray N. Wattanachit J. Niemi A. H. Kanji K. House E. Y. Cramer J. Bracher A. Zheng T. K. Yamana X. Xiong S. Woody Y. Wang L. Wang R. L. Walraven V. Tomar K. Sherratt D. Sheldon R. C. Reiner B. A. Prakash D. Osthus M. L. Li E. C. Lee U. Koyluoglu P. Keskinocak Y. Gu Q. Gu G. E. George G. España S. Corsetti J. Chhatwal S. Cavany H. Biegel M. Ben-Nun J. Walker R. Slayton V. Lopez M. Biggerstaff M. A. Johansson N. G. Reich Ensemble Forecasts of Coronavirus Disease 2019 (COVID-19) in the U.S.. Medrxiv 2020.08.19.20177493 (2020); https://doi.org/10.1101/2020.08.19.20177493. · DOI · Paper page
- 10.1016/j.nmni.2021.100877 · DOI
- 10.1371/journal.ppat.1009499 · DOI
- 10.1016/j.advms.2021.03.005 · DOI
- 10.1016/j.cell.2020.08.012 · DOI · Paper page
- 10.1016/j.xcrm.2021.100355 · DOI · Paper page
- 10.1093/molbev/msi105 · DOI · Paper page
- 10.1093/molbev/msz197 · DOI · Paper page
- 10.1016/j.cell.2021.09.003 · DOI · Paper page
- 10.2174/156802608786786624 · DOI · Paper page
- 10.1093/ije/dyw328 · DOI
- A. L. Cathcart C. Havenar-Daughton F. A. Lempp D. Ma M. A. Schmid M. L. Agostini B. Guarino J. D. Iulio L. E. Rosen H. Tucker J. Dillen S. Subramanian B. Sloan S. Bianchi D. Pinto C. Saliba J. A. Wojcechowskyj J. Noack J. Zhou H. Kaiser A. Chase M. Montiel-Ruiz E. Dellota A. Park R. Spreafico A. Sahakyan E. J. Lauron N. Czudnochowski E. Cameroni S. Ledoux A. Werts C. Colas L. Soriaga A. Telenti L. A. Purcell S. Hwang G. Snell H. W. Virgin D. Corti C. M. Hebner The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2. biorxiv 2021.03.09.434607 [ Preprint ] (2021); https://doi.org/10.1101/2021.03.09.434607. · DOI · Paper page
- 10.1038/s41586-021-03807-6 · DOI · Paper page
- 10.1016/j.bbrc.2020.11.075 · DOI
- 10.1038/s41421-021-00268-z · DOI · Paper page
- 10.1016/j.celrep.2020.108185 · DOI · Paper page
- 10.1016/S1473-3099(17)30238-4 · DOI
- 10.1093/nar/gkaa1053 · DOI · Paper page
Cited by
Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00878-2 · Cited by 1,179
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics
Zvyagin, M., Brace, A., Hippe, K., Deng, Y., Zhang, B., Bohorquez, C. O., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., et al. (2023) · The International Journal of High Performance Computing Applications · doi:10.1177/10943420231201154 · Cited by 120
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics
Zvyagin, M., Brace, A., Hippe, K., Deng, Y., Zhang, B., Bohorquez, C. O., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., et al. (2022) · doi:10.1101/2022.10.10.511571 · Cited by 120
RASCL: Rapid Assessment Of SARS-CoV-2 Clades Through Molecular Sequence Analysis
Lucaci, A. G., Zehr, J. D., Shank, S. D., Bouvier, D., Mei, H., Nekrutenko, A., Martin, D. P., & Kosakovsky Pond, S. L. (2022) · doi:10.1101/2022.01.15.476448 · Cited by 2
Metadata
- Authors
- Maher, M. C., Bartha, I., Weaver, S., di Iulio, J., Ferri, E., Soriaga, L., Lempp, F. A., Hie, B. L., Bryson, B., Berger, B., Robertson, D. L., Snell, G., Corti, D., Virgin, H. W., Kosakovsky Pond, S. L., & Telenti, A.
- Venue
- Science Translational Medicine
- Published
- 2022-02-23
- Volume
- 14
- Issue
- 633
- Pages
- eabk3445-eabk3445
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4225492776
- Cited by
- 184
- References
- 22
- FWCI
- 18.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting the mutational drivers of future SARS-CoV-2 variants of concern. https://app.cochat.ai/papers/10.1126/scitranslmed.abk3445
- The paper
- Maher, M. C., Bartha, I., Weaver, S., di Iulio, J., Ferri, E., Soriaga, L., Lempp, F. A., Hie, B. L., Bryson, B., Berger, B., Robertson, D. L., Snell, G., Corti, D., Virgin, H. W., Kosakovsky Pond, S. L., & Telenti, A. (2022). Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abk3445
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
